Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4D2K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,938
Award facts
- Contract value 100% obligated
- $57,937.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $57,937.50 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of December 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement with the Defense Logistics Agency, which enables the company to distribute a wide range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. Biktarvy is an antiretroviral medication used in HIV treatment, reflecting the breadth of specialty pharmaceuticals supplied through the DLA Medical Supply Chain. The contract was not set aside and was competitively awarded, demonstrating AmerisourceBergen's continued capability to meet federal medical procurement requirements alongside other pharmaceutical vendors participating in the DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DR26F4D2K?
SPE2DR26F4D2K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F4D2K worth?
The government has obligated $57,938 on SPE2DR26F4D2K.
Is contract SPE2DR26F4D2K an order under another contract?
Yes. SPE2DR26F4D2K is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4D2K competed?
The extent of competition for SPE2DR26F4D2K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award